机构：[1]School of Medicine, University of Electronic Science and Technology of China,Chengdu 610054, China四川省人民医院[2]Department of Radiation Oncology, SichuanCancer Hospital and Institute, Sichuan Cancer Center, Radiation OncologyKey Laboratory of Sichuan Province, Chengdu 610041, China四川省肿瘤医院[3]Departmentof Health Technology and Informatics, The Hong Kong Polytechnic University,Hongkong 999077, China[4]Department of Oncology, The Affiliated Hospitalof Southwest Medical University, Luzhou 646000, Sichuan, China
(No: 2021-DF-016) of Elekta
AB (Stockholm, Sweden). The funders had no role in study design, data collection
and analysis, and decisions on preparation of the manuscript. This study
was partially supported by Sichuan Science and Technology Program (No.
2022YFG0194, No. 2022YFS0047, No. 2021YFG0320) and Medical Engineering
Innovation Fund for Cancer (No. ZYGX2021YGCX002).
语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类|2 区医学
小类|2 区核医学3 区肿瘤学
最新[2023]版：
大类|2 区医学
小类|2 区核医学3 区肿瘤学
JCR分区：
出版当年[2022]版：
Q2ONCOLOGYQ2RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2023]版：
Q1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGQ2ONCOLOGY
第一作者机构：[1]School of Medicine, University of Electronic Science and Technology of China,Chengdu 610054, China[2]Department of Radiation Oncology, SichuanCancer Hospital and Institute, Sichuan Cancer Center, Radiation OncologyKey Laboratory of Sichuan Province, Chengdu 610041, China
通讯作者：
通讯机构：[1]School of Medicine, University of Electronic Science and Technology of China,Chengdu 610054, China[2]Department of Radiation Oncology, SichuanCancer Hospital and Institute, Sichuan Cancer Center, Radiation OncologyKey Laboratory of Sichuan Province, Chengdu 610041, China
推荐引用方式(GB/T 7714)：
Wen Aiping,Wang Xianliang,Wang Bingjie,et al.Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer[J].RADIATION ONCOLOGY.2022,17(1):doi:10.1186/s13014-022-02170-8.
APA：
Wen Aiping,Wang Xianliang,Wang Bingjie,Yan Chuanjun,Luo Jingyue...&Li Jie.(2022).Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.RADIATION ONCOLOGY,17,(1)
MLA：
Wen Aiping,et al."Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer".RADIATION ONCOLOGY 17..1(2022)
